Paid Clinical Trials in Meridian, ID
As of September 2026, 101 paid clinical trials are recruiting in Meridian, Idaho. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Meridian offers studies at sites including Saint Luke's Cancer Institute - Meridian for conditions such as Obesity, Acute Myeloid Leukemia, Overweight, Anatomic Stage II Breast Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Meridian
Trials by drug in Meridian
Filter results
Newly added in Meridian
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
98 clinical trials
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
A Long-Term Follow-Up Study of Participants Exposed to REACT
REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Family Communications After Genetic Testing
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Top Research Study Locations in Meridian
Researchers run research studies in Meridian, ID at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Saint Luke's Cancer Institute - Meridian | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Malignant Solid Neoplasm | 60 |
| Idaho Urologic Institute-Meridian | Malignant Solid Neoplasm, Chronic Lymphocytic Leukemia, Hematopoietic and Lymphoid Cell Neoplasm | 26 |
| Solaris Clinical Research | Overweight, Obesity, Obesity or Overweight | 5 |
| Velocity Clinical Research - Boise | Atherosclerotic Cardiovascular Disease, Diabetic Peripheral Neuropathic Pain, Obesity | 4 |
| Ada West Research | Eczema, Pyoderma Gangrenosum, Severe Alopecia Areata | 3 |
| Boise Kidney & Hypertension Institute | Diabetic Kidney Disease, Chronic Kidney Disease, Chronic Kidney Diseases | 2 |
| GSK Investigational Site | Influenza, Human, Irritable Bowel Syndrome | 2 |
| ACCOMPLISH-1 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| ACCOMPLISH-2 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| Ada West Research - Meridian | Atopic Dermatitis | 1 |
| Ada West Research, LLC | Atopic, Atopic Dermatitis, Dermatitis | 1 |
| CARE Institute - High Desert | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 1 |
| Care Institute- High Desert | Diabetes Mellitus, Type 2, Metabolic Syndrome, PreDiabetes | 1 |
| High Desert Heart & Vascular | Atherosclerosis, Cardiovascular Diseases, Lipoprotein(a) | 1 |
| High Desert Heart and Vascular | Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Obesity | 1 |
| High Desert Heart and Vascular PLLC | Heart Failure, Obesity | 1 |
| Idaho Physical Medicine and Rehabilitation | Lumbar Spinal Stenosis | 1 |
| Idaho Urologic Institute | Prostate Cancer Detection | 1 |
| Meridian | Endometriosis, Uterine Fibroids | 1 |
| Mountain View Surgical Center | Lumbar Spinal Stenosis | 1 |
| St Luke's Clinic - Neurology | Menstrual Migraine | 1 |
| St Lukes Idaho | Cardiovascular Disease | 1 |
| St. Luke's Clinic - Idaho Cardiology Associates | Atherosclerosis, Coronary Artery Disease | 1 |
| St. Luke's Idaho Cardiology Associates | Heart Failure, Obesity | 1 |
| St. Luke's Idaho Pulmonary Associates - Meridian Clinic | OSA | 1 |
Active & Upcoming Studies in Meridian (2026)
Recruiting trials in Meridian grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (57 active studies)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
- Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL · Phase 3 · Alliance for Clinical Trials in Oncology
Diabetes & metabolic (11 active studies)
- A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity · Phase 3 · Eli Lilly and Company
- A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar · Phase 3 · Boehringer Ingelheim
Neurology & pain (4 active studies)
- A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine · Phase 3 · Pfizer
- Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy · Phase 3 · Vertex Pharmaceuticals Incorporated
Cardiovascular (3 active studies)
- A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis · Phase 2 · Beijing Inno Medicine Co., Ltd.
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Vaccines (1 active study)
- A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age · Phase 3 · GlaxoSmithKline
Mental health & behavior (1 active study)
- REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool · Phase 3 · Senseye, Inc.
Common conditions studied in Meridian
- Obesity (7 active studies)
- Acute Myeloid Leukemia (6 active studies)
- Overweight (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Malignant Solid Neoplasm (4 active studies)
- Stage IIIB Lung Cancer AJCC v8 (3 active studies)
Leading research sponsors in Meridian
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- SWOG Cancer Research Network
- Amgen
- ECOG-ACRIN Cancer Research Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Meridian?
There are approximately 101 recruiting clinical trials in Meridian, Idaho listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Meridian pay participants?
Most recruiting trials in Meridian compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Meridian?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Meridian?
The most common conditions under active study in Meridian include Obesity (7), Acute Myeloid Leukemia (6), Overweight (6), Anatomic Stage II Breast Cancer AJCC v8 (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Meridian?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Meridian on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Meridian?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Meridian?
Recruiting research sites in Meridian include Saint Luke's Cancer Institute - Meridian, Idaho Urologic Institute-Meridian, Solaris Clinical Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Meridian right now?
The largest active categories in Meridian are Cancer & tumors (57), Diabetes & metabolic (11), Neurology & pain (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.